CLINICAL_TRIALS
research
· 2026-02-02
Clinical Trial Update: Surgery for Recurrent Glioblastoma [Phase 2]
Summary
A Phase 2 clinical trial assessing surgical treatment for recurrent glioblastoma is currently recruiting, sponsored by Insel Gruppe AG and University Hospital B…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Glioblastoma | Phase 2 | Status: RECRUITING